Neuromuscular Biology & Disease Groupat the Boston University School of Medicine
Our goals are to identify pathogenetic mechanisms and to develop new therapeutic strategies for neuromuscular diseases.
April 1st, 2010
Our paper on the role of Prdm1 in muscle development and fiber type diversification has been published by PLoS One. (read it)